Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study

Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study

Background: Erenumab, a fully human monoclonal antibody targeting the calcitonin gene-related peptide pathway, was developed specifically for preventive treatment of migraine. Objective: To compare the real-world effectiveness of erenumab and non-specific oral migraine preventive medication (OMPM) o...

Full description

Bibliographic Details
Main Authors: Stewart J Tepper, Juanzhi Fang, Lujia Zhou, Pamela Vo, Ahmad Abdrabboh, Mrudula Glassberg, Matias Ferraris
Format: Article
Language:English
Published: SAGE Publishing 2021-09-01
Series:Cephalalgia Reports
Online Access:https://doi.org/10.1177/25158163211040061

Internet

https://doi.org/10.1177/25158163211040061

Similar Items